OCS
Oculis Holding AG trades as OCS and has a market capitalization of $1.74 B, making it the #2258 largest US-listed company by market value. This page tracks Oculis Holding AG through 130 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-05-29
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-14 |
| 6-K | - | 2026-05-11 |
| SCHEDULE 13G/A | - | 2026-04-29 |
| 6-K | - | 2026-04-21 |
| SCHEDULE 13G/A | - | 2026-03-27 |
| Insider sale notice | 144 | 2026-03-09 |
| 6-K | - | 2026-03-04 |
| F-3ASR | - | 2026-03-04 |
Oculis Reports Q1 2026 Financial Results and Provides Company Update | Oculis
Oculis Reports Q2 2025 Financial Results and Provides Company Update | Oculis
Oculis Reports Q1 Financial Results and Provides Company Update | Oculis
The largest companies sharing Oculis Holding AG's SEC industry classification (pharmaceutical preparations).
Oculis Holding AG (OCS) has a market capitalization of $1.74 B as of 2026-05-29, ranking #2258 among US-listed companies.